HBC eyes 2022 launch for consumer health brand as R&D projects take off

However, the company reports declining EBITDA amid halted calcium production

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

Hofseth Biocare (HBC) has received a new dietary ingredient (NDI) status from the US Food and Drug Administration (FDA) for its CalGo and OmeGo products. 

FormattedPicture

NUTRITION & HEALTH NEWS

Increased consumer demand for immunity products ahead of the winter season is a key driver behind BioGaia’s growth, according to the Sweden-based company. It has... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Vitamin K2 is poised to emerge “as one of the most important supplemental nutrients,” following the latest research on its role in immunity and COVID-19.... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

French company HPE Ingredients is unveiling two snail-based ingredients that support digestive health and tackle calcium deficiencies – Helidigest and Helishell.... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

US-based biotech company Cypress Systems is launching a premium ingredient line of pure, fully-reacted chelated minerals branded TheChelates.

trans